Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-37759 OUTLOOK THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 38-3982704 (Sta ...

Corporate Presentation September 2022 NASDAQ: OTLK outlooktherapeutics.com | --- | --- | --- | |---------------|---------------------------------------------------------------------------------------|-------| | | | | | | Enhancing the standard of care for retinal disorders by working to achieve the first | | | ophthalmology | FDA approval for bevacizumab in | 2 | Disclaimer This presentation contains forward-looking statements about Outlook Therapeutics, Inc. ("Outlook Therapeutics" or the "Company") based ...

Corporate Presentation May 2022 NASDAQ: OTLK outlooktherapeutics.com | --- | --- | --- | |---------------|------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | Enhancing the standard of care for retinal disorders by working to achieve the first FDA approval for bevacizumab in | | | ophthalmology | | 2 | Disclaimer This presentation contains forward-looking statements about Outlook Therapeutics, Inc. ("Outlook Therapeutic ...

Corporate Presentation October 2021 NASDAQ: OTLK outlooktherapeutics.com Disclaimer This presentation contains forward-looking statements about Outlook Therapeutics, Inc. ("Outlook Therapeutics" or the "Company") based on management's current expectations, which are subject to known and unknown uncertainties and risks. Words such as "anticipated," "initiate," "expect," "intend," "plan," "believe," "seek," "estimate," "may," "will," and variations of these words or similar expressions are intended to identif ...

CORPORATE PRESENTATION August 2021 NASDAQ: OTLK outlooktherapeutics.com Disclaimer This presentation contains forward-looking statements about Outlook Therapeutics, Inc. ("Outlook Therapeutics" or the "Company") based on management's current expectations, which are subject to known and unknown uncertainties and risks. Words such as "anticipated," "initiate," "expect," "intend," "plan," "believe," "seek," "estimate," "may," "will," and variations of these words or similar expressions are intended to identify ...

CORPORATE PRESENTATION September 2019 DISCLAIMER This presentation contains forward-looking statements about Outlook Therapeutics, Inc. ("Outlook Therapeutics" or the "Company") based on management's current expectations, which are subject to known and unknown uncertainties and risks. Words such as "anticipated," "initiate," "expect," "intend," "plan," "believe," "seek," "estimate," "may," "will," and variations of these words or similar expressions are intended to identify forward-looking statements. These ...